Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

These 5 Healthcare Penny Stocks Are Poised To Jump

Penny stocks are a risky investment, as many such companies have a product or products that are a long way from generating revenues (if they’re ever able to at all). However, if an investor can pick out the right candidate among these penny stocks, the future returns can be substantial. In order to increase these odds, we have decided to share five penny stocks from the healthcare sector that are the most popular among the hedge funds from our database, which implies that these money managers have rigorously researched these companies before assigning them a place in their equity portfolios. You can be sure that when these elite investors are collectively taking stakes in such obscure stocks, there is something noteworthy happening with those companies.

Most Advanced Countries in Medicine

everything possible/

We track hedge funds and prominent investors because our research has shown that historically their stock picks delivered superior risk-adjusted returns. This is especially true in the small-cap space. The 50 most popular large-cap stocks among hedge funds had a monthly alpha of about six basis points per month between 1999 and 2012; however the 15 most popular small-cap stocks delivered a monthly alpha of 80 basis points during the same period. This means investors would have generated ten percentage points of alpha per year simply by imitating hedge funds’ top 15 small-cap ideas. We have been tracking the performance of these stocks since the end of August 2012 in real time and these stocks beat the market by over 60 percentage points (118% return vs. the S&P 500’s 57.6% gain) over the last 36 months (see the details here).

5. InspireMD Inc (NYSEMKT:NSPR)

Investors with Long Positions (as of June 30): 7

Aggregate Value of Investors’ Holdings (as of June 30): $3.02 Million  

Even though the stock price of the $14.79 million medical device company has fallen by more than 76% so far this year, the hedge fund interest in the company has largely remained the same, with a reduction of one fund from the total number of investors during the second quarter, and a $1.67 million decrease in their total investments, mostly on the back of stock depreciation during the period. The hedge fund concentration in the company at the end of June amounted to 13.8% of InspireMD’s total shares. The biggest dip for InspireMD Inc (NYSEMKT:NSPR)’s stock came in early March when the company announced a public offering for $13.5 million. Steven Boyd‘s Armistice Capital is the largest stockholder of InspireMD Inc (NYSEMKT:NSPR), holding about 6.56 million shares valued at $1.84 million, and representing 8.41% of the company’s outstanding shares.

Follow Inspiremd Inc. (NYSEMKT:NSPR)

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.